100 Vanguard Boulevard,
Malvern , PA, 19355
Malvern , PA, 19355
Summary
The fund seeks to track the total return performance of a benchmark index by investing in mega-and large-size companies in the United States.
The investment process employs an indexing investment approach to track the performance of the CRSP US Large Cap Value Index.
The process seeks to replicate the composition of the benchmark index, holding each security in approximately the same proportion as its weighting in the Index More
Link
Directors
Mar 13, 2024- Deanna Mulligan
- David Thomas
- F. Joseph Loughrey
- Mortimer J. Buckley
- Peter F. Volanakis
- Grant Reid
- Tara Bunch
- Mark Loughridge
- Scott C. Malpass
- Andre F. Perold
- Sarah Bloom Raskin
- Emerson U. Fullwood
Chief Compliance Officer
- Jacqueline Angell
Fund Manager(s)
- Gerard O’Reilly
- Walter Nejman
Price
- 52-Week High/Low
- $69.36 - $52.62
- Turnover
- 8.9%
- Expense Ratio
- 0.04%
Company Name |
Holding |
| Procter & Gamble Co/The | 1.89 % |
| Merck & Co Inc | 1.52 % |
| AbbVie Inc | 1.47 % |
| Thermo Fisher Scientific Inc | 1.03 % |
| Amgen Inc | 0.81 % |
| Honeywell International Inc | 0.68 % |
| AT&T Inc | 0.67 % |
| NextEra Energy Inc | 0.67 % |
| ConocoPhillips | 0.65 % |
| Goldman Sachs Group Inc/The | 0.64 % |
| More | 0.64 % |
Documents
Performance
YTD
6.1%
3 Year
20.14%
5 Year
49.84%
Best
31.72%
2003
Worst
-22.2%
2002
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 9.1% | -1.6% | 0.5% | 10.3% | -25.7% | 10% | -2.3% | 3.3% | 1.6% | -0.6% |
| Q2 | -2.2% | 2.9% | -10.9% | 6.5% | 11.9% | 1.9% | 3.4% | 1.8% | 3.8% | 0.5% |
| Q3 | - | -2.9% | -6.4% | -3.3% | 3.1% | -0.1% | 7.1% | 4.2% | 3% | -7.3% |
| Q4 | - | 9.4% | 13.8% | 9.3% | 13.9% | 7.4% | -11.3% | 6.4% | 7.5% | 7% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 0.9% | 3.4% | 4.5% | -2.7% | - | - | - | - | - | - | - | - |
| 2023 | 2.8% | -3.2% | -1.1% | 1.8% | -4.1% | 5.5% | 3.4% | -2.4% | -3.9% | -2.7% | 6.7% | 4.3% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6% | 6% | -5% | 24% | -1% | 23% | 0% | 17% | 17% | -1% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| VIVIX | 6% | 6% | -5% | 24% | -1% | 23% | - | 17% | 17% | -1% |
| Russell 1000 | - | - | -14% | 23% | 0% | 23% | -11% | 11% | 14% | -6% |
| Alpha | 6% | 6% | 9% | 1% | -1% | -1% | - | 6% | 3% | 5% |